
<DOC>
<DOCNO>
WSJ900706-0144
</DOCNO>
<DOCID>
900706-0144.
</DOCID>
<HL>
   Technology:
   Cyanamid Co-Marketing Pact
</HL>
<DATE>
07/06/90
</DATE>
<SO>
WALL STREET JOURNAL (J), NO PAGE CITATION
</SO>
<CO>
   ACY AHP ELN
</CO>
<IN>
DRUG MANUFACTURERS (DRG)
</IN>
<LP>
   WAYNE, N.J. -- The Lederle Laboratories division of
American Cyanamid Co. said it reached an agreement with
American Home Products Corp. to co-market Verelan, an
antihypertensive drug.
   Lederle has licensed U.S. marketing rights to the drug, a
calcium channel blocker known generically as verapamil, from
Elan Corp. of Ireland. Lederle said its sales force will
begin selling the drug this month along with two divisions of
American Home, Wyeth-Ayerst Laboratories and A.H. Robins Co.
</LP>
<TEXT>
</TEXT>
</DOC>